Cellectar Biosciences Inc (CLRB) is near the top in its sector according to InvestorsObserver.
CLRB gets an overall rating of 71. That means it scores higher than 71% of stocks.
Cellectar Biosciences Inc gets a 90 rank in the Healthcare sector. Healthcare is number 6 out of 11 sectors.
What do These Ratings Mean?
Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies in the healthcare sector can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the best stocks in that sector.
Not only are these scores easy to understand, but it is easy to compare stocks to each other. You can find the best stock in healthcare or look for the sector that has the highest average score.
The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.)
What's Happening With Cellectar Biosciences Inc Stock Today?
Cellectar Biosciences Inc (CLRB) stock has risen 10.56% while the S&P 500 is down -0.24% as of 2:53 PM on Tuesday, Feb 18. CLRB has risen $0.31 from the previous closing price of $2.93 on volume of 657,910 shares. Over the past year the S&P 500 is higher by 21.31% while CLRB has risen 67.01%. CLRB lost -$2.36 per share the over the last 12 months.
To see InvestorsObserver's Sentiment Score for CLRB click here.
